Takeda-backed Ascentage Pharma files for $100M IPO

Initial public offering hologram, night panoramic city view of Bangkok. The financial center for multinational corporations in Asia. The concept of boosting the growth by IPO process. Double exposure.

2d illustrations and photos

Takeda-backed Ascentage Pharma Group (AAPG) has filed to raise up to $100M through a U.S. initial public offering.

The Chinese drug developer didn’t specify terms in its SEC filing, but indicated in a filing fee schedule that it was looking

Leave a Reply

Your email address will not be published. Required fields are marked *